A Study to Evaluate Efficacy of Ivacaftor in Subjects With Cystic Fibrosis Who Have a 3849 + 10KB C→T or D1152H CFTR Mutation
Clinical trial NCT03068312 · COMPLETED
Trial details
- NCT number
- NCT03068312
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-18
- Primary completion
- 2018-12-18
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.